These emerging therapies, including Semaglutide , belong to a group of drugs called GLP-1 receptor agonists . Primarily developed for controlling diabetes mellitus , they function by encouraging the body to secrete adequate the hormone insulin and reducing high sugar levels. Furthermore , their capacity to promote weight loss has resulted to sub… Read More